Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)

As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS